Skip to main content
Device Global Header

Subscribe
or Renew

Advanced Search

This article is available to subscribers. Subscribe now. Already have an account? Sign in

Medical ProgressFree PreviewArchive

Clinical Use of Lactic Dehydrogenase

List of authors.
  • Russell J. Erickson, M.D.†,
  • and Daniel R. Morales, B.S., M.S.‡

THE determination of lactic dehydrogenase (LDH) activity has received attention in several medical centers both as an investigative tool and as a clinical laboratory procedure because of the promise that it has shown in the diagnosis and prognosis of certain diseases. However, conflicting results, diverse methods of assay and different methods used to express LDH have produced a picture that is often difficult to interpret. In undertaking this review of the literature, we have kept in mind both the investigator in this field and the practicing physician who wishes to familiarize himself with the current status of LDH in medicine, . . .

Funding and Disclosures

* From the Cancer Research Institute, University of California School of Medicine.

Supported by the Al Holman Memorial Cancer Foundation Scholarship Fund and by Public Health Service grants for undergraduate cancer training (CT 493) and for chemotherapy and pathophysiology in clinical cancer (CY 3422).

Author Affiliations

SAN FRANCISCO

† Intern, Department of Pediatrics, University of California School of Medicine.

‡ Ph.D. candidate, Department of Biochemistry, University of California School of Medicine.

Print Subscriber? Activate your online access.